Progesterone has been known to play a significant role in the facilitation of implantation and in the maintenance of pregnancy. This critical influence of progesterone is most likely due to its well-known ability to inhibit uterine contractility and to suppress the immune response to the fetus. 1, 2) During pregnancy as well as the luteal phase of the menstrual cycle after ovulation, progesterone is essential for reproductive function.
During pregnancy as well as the luteal phase of the menstrual cycle after ovulation, progesterone is essential for reproductive function. 3, 4) Therefore, progesterone can be utilized as a marker for the diagnosis of early pregnancy. Antibodies that bind specifically to progesterone are essential in developing immunoassay methods to measure the progesterone level.
Fluorescence polarization immunoassay (FPIA) is based on the principles of two technologies: competitive antibody binding and fluorescence polarization. The competitive antibody-binding assay is based on the competition between free progesterone and fluorescence-labeled progesterone tracer for the binding site on the antibody. The fluorescence polarization assay is based on the principle that molecules rotate in liquid and the rate of rotation is related to the size of the molecule. The disturbance of polarized fluorescence is higher in a small fluorescence-labeled antigen (tracer) than in antibody-bound tracer. When a small fluorescence molecule is excited with polarized light, its rapid Brownian rotation leads to randomization of the molecular orientation before fluorescence emission occurs, and the polarization becomes low. If the molecule binds to a large specific antibody (MW 150000 Da), rotation slows and the emitted fluorescence retains substantial polarization. Hence the degree of antibody binding may be monitored by measurement of fluorescence polarization without physical separation steps.
Because of the dependence on molecular size in FPIA, it is particularly suited to the assay of small haptens such as steroids and drugs. Its major applications are in clinical diagnostics, especially in the areas of therapeutic drug monitoring and drug-abuse screening. 5, 6) A fully automated instrument, the Abbott TDx analyzer, incorporating a polarization fluorometer and a versatile diluter-dispenser has been introduced. For progesterone-related investigations, several hybridoma cell lines producing monoclonal antibodies against immunogens of conjugation-site specific progesterone have been established, as previously described. 7, 8) Several immunoassays were reported such as enzyme immunoassay (EIA), 7) cytometric fluoroimmunoassay (CFIA), 9) visual membrane EIA, 8) and FPIA to measure progesterone levels. 10) In this investigation, an immunocomplex single reagent (SR) is developed to simplify the FPIA procedure (one-step FPIA) and its performance characteristics were evaluated in determining progesterone levels. were of analytical grade, and the solutions were prepared in deionized water using the Milli-Q water purification system (Millipore Inc., MA, U.S.A.).
MATERIALS AND METHODS

Instruments and Chemicals
Working standard solutions of progesterone in the range of 0.1-10000 ng/ml were prepared by dilution of stock solution (1 mg/ml in ethanol and further diluted to 10 mg/ml with PBS) with synthetic urine 10) and stored at 4°C. The same method was used to prepare cross-reactant standards.
The TDx analyzer (Abbott Labs, TX, U.S.A.) in photocheck mode was used to measure the fluorescence polarization resulting from antibody binding of the tracer and tracer displacement in FPIA.
Preparation of Fluorescence-Labeled Tracers Ethylenediamine fluoresceinthiocarbamyl (EDF), as a fluorescein label, was synthesized as described by Pourfarzaneh et al. 11) and the fractionation step followed as reported previously. 12) Fluorescence-labeled P-11HS conjugate tracer (P-11HS-EDF) was prepared as follows. P-11HS (5.0 mg, 11.6 mmol), NHS (5.4 mg, 46.6 mmol), and EDC (17.8 mg, 92.8 mmol) in 2 ml of DMF were stirred at room temperature for 2 h to prepare active ester of P-11HS, and then EDF (5.2 mg, 11.6 mmol) was added. The reaction mixture was stirred for 4 h at room temperature in the dark and allowed to stand overnight at 4°C. Solvent was removed, and the residue was dissolved in methanol. The product was purified on a TLC plate (chloroform : methanol, 4 : 1). Two yellow bands (Rfϭ 0.3, 0.9) were scraped from the plate and extracted with a solvent of CHCl 3 : CH 3 OH (4 : 1). The tracers were stored in the dark at 4°C. The concentration of tracer was estimated spectrophotometrically at 492 nm using an extinction coefficient of 8.78ϫ10 4 
M
Ϫ1 · cm Ϫ1 in 50 mM sodium carbonate buffer, pH 9.0.
11) The P-3CMO-EDF was synthesized in the same way as P-11HS-EDF using P-3CMO in place of P-11HS. Two products (Rfϭ0.3, 0.8) were obtained by TLC purification. Four different fluorescence-labeled tracers (P-11HS-AF1 and AF2, P-3CMO-AF1 and AF2) were synthesized in the same way as P-11HS-EDF using a combination of two progesterone derivatives (P-11HS and P-3CMO) and AF1 and AF2.
Preparation of Progesterone-BSA Immunogen Immunogens for antisera production were prepared by the following method. P-11HS (4 mg, 9.3 mmol), NHS (3 mg, 26 mmol), and dicyclohexylcarbodiimide (3 mg, 14.5 mmol) were dissolved in DMF (0.5 ml) and stirred slowly for 2 h until a precipitate of dicyclohexylurea was formed. The reaction mixture was centrifuged at 2800 rpm for 20 min. A solution of BSA (4 mg) in 50 mM carbonate buffer (2 ml), pH 9.6, containing 0.15 M KCl was added to the resulting supernatant. After mixing slightly at room temperature for 2 h, the insoluble solids were removed by centrifugation. The P-11HS-BSA conjugate was pool and dialyzed with PBS at 4°C and profiled by reading the absorbance at 280 nm. P-3CMO-BSA was prepared in the same way as P-11HS-BSA using P-3CMO in place of P-11HS.
Preparation of Progesterone Antiserum Progesterone antisera were developed in rabbits initially immunized with CFA emulsion using progesterone-BSA immunogens, followed by two booster injections with IFA emulsion at 3-week intervals. Two types of antisera, PAb #1 and PAb #2, were obtained from the third blood sample from rabbits that were immunized with P-11HS-BSA and P-3CMO-BSA immunogen, respectively.
FPIA for Assessment of the Titration Level To prepare antibody titration curves, 0.5 ml of tracer solution (10 nM) was added to each serial dilution of antiserum (0.5 ml) in PBS. The polarization of fluorescence was measured using the Abbott TDx analyzer set in the photo-check mode. A dilution curve was constructed by plotting the fluorescence polarization in millipolarization units (mP) against the dilution of the antiserum.
Immunocomplex SR and One-Step FPIA for Dose-Response Curve To prepare the immunocomplex SR, 50 ml of 60-fold diluted antiserum with PBS and 50 ml of diluted tracer with PBS were mixed for 2 h at room temperature to set 2000 units of intensity and stored at 4°C. This immunocomplex SR solution in 10 mM PBS, pH 7.2, contained 5 nM of tracer and antiserum that was diluted to produce approximately 70% of maximum binding. To generate a dose-response curve, 50 ml of progesterone standard solution was mixed with 1 ml of immunocomplex SR, and mP was measured without incubation time using the photo-check mode of the Abbott TDx analyzer.
RESULTS AND DISCUSSION
Synthesis of Fluorescence Labeled
Tracer and Antibody Assessment by FPIA Progesterone antisera produced by rabbits were PAb #1 (P-11HS-BSA immunogen) and PAb #2 (P-3CMO-BSA immunogen). The titer level of each antiserum was assessed by FPIA of serially diluted antiserum with the respective fluorescence-labeled tracesr P-11HS and P-3CMO. Fluorescence-labeled tracer is an important component in FPIA, and the sensitivity and specificity depend on the characteristics of the tracer.
12) For this reason, nine fluorescence-labeled tracers were synthesized using two progesterone derivatives of P-11HS and P-3CMO and three fluorescence labels, AF1, AF2, and EDF. Table 1 shows the chemical structure of progesterone derivatives and tracers. The tracers were synthesized by coupling the carboxyl group of the progesterone derivative to the amine group of fluorescein to form an amide bond between progesterone and fluorescein. The tracers were separated by TLC using a solvent (CHCl 3 : CH 3 OH, 4 : 1). The fluorescent bands of proper Rf value were scraped, extracted, and purified using a solvent of CHCl 3 : CH 3 OH (4 : 1) ( Table 1 ). All tracers were checked for binding with both antisera by FPIA.
Titration curves of the antisera PAb #1 and PAb #2, are shown in Fig. 1 . Different binding responses were seen depending on the tracer used. We used 2000 units of fluorescence intensity in 10 mM PBS, which is equivalent to 22.6 mM as fluorescein (extinction coefficient: 8.78ϫ10 4 
M
Ϫ1 · cm Ϫ1 ) 11) and produced approximately 30-40 mP of fluorescence polarization with free tracer. Considering the background of fluorescence polarization of free tracer (ca. 40 mP), the fluorescence polarization of antibody-bound tracer (ca. 350 mP) with 1 : 60 diluted antibody is approximately 8 times higher than the background signal, which is sufficient to distinguish the displacement differences by the concentration range of progesterone standards.
We evaluated nine tracers for both antibodies of PAb #1 and PAb #2 in terms of sensitivity based on the dose-response curve of displacement. Several studies have reported that the high degree of displacement is based on the selection of antibodies with the highest dissociation constants to tracers, 13, 14) and that the titer level of antibody does not exactly correlate with the sensitivity of the immunoassays. 15, 16 ) PAb #1 and P-11HS-EDF (Rfϭ0.9) were the best in FPIA, showing sensitivity of 10 ng/ml (Fig. 2) . The following is the structure of a synthesized tracer of P-11HS-EDF (Rfϭ0.9) confirmed by 1 Some tracers produced dose-response displacements, but the sensitivity was 4 orders of magnitude less. These pairs were PAb #1 with tracers of P-3CMO-EDF (Rfϭ0.8) and P-11HS-AF1 (Rfϭ0.5), and PAb #2 with the tracers P-3CMO-AF2 (Rfϭ0.5), P-3CMO-EDF (Rfϭ0.8), and P-11HS-AF1 (Rfϭ0.9). From the results, we found that the tracer performs better with antibody of which the immunogen has a chemical structure closer to that of the tracer.
Preparation of Immunocomplex SR The antiserum PAb #1 and tracer P-11HS-EDF were selected for optimization of FPIA to determine progesterone levels. To simplify the FPIA procedure further, a new method was studied using an immunocomplex SR that is a preequilibrated mixture of antiserum and tracer in 10 mM PBS, pH 7.2. Appropriate dilutions of antibody and tracer and the kinetic parameters of tracer binding and displacement were studied to produce sensitive standard curves. The immunocomplex SR was prepared to produce 150 mP of fluorescence polarization without antibody, which is equivalent to 2000 units of fluorescence intensity. The appropriate amount of antiserum was estimated from the antibody dilution curve and used to produce 70% mP for maximum binding of antibody. The kinetics for tracer dissociation from the immunocomplex SR upon adding various concentrations of progesterone (10 ng/ml-10 mg/ml) are shown in Fig. 3 . The dissociation of tracer was completed within 5 min regardless of the progesterone concentration. However, strength of the tracers dissociation signal was proportional to the progesterone concentration, showing decreased polarization with the increasing concentration of progesterone.
Performance of One-Step FPIA Optimized conditions for one-step FPIA were established. For the performance of one-step FPIA, 50 ml of standard or sample was mixed with 1 ml of the immunocomplex SR and fluorescence polarization was measured without incubation using the Abbott TDx analyzer in photo-check mode. The analysis takes 7 min for 10 samples. The standard curve was nonlinear by plotting the (Fig. 4) , however, yielded a linear response (rϭ0.990). The reproducibility of the standard curve (nϭ3) was evaluated by comparing both the slope and intercept of each standard curve generated from mP units against the log concentration ( Table 2 ). The mean slope was Ϫ11.2 (6.1% CV), average intercept 156.5 (0.6% CV), and correlation coefficient 0.998 (0.2% CV). This means that the standard curve using the immunocomplex SR is fairly stable and reproducible. When the immunocomplex SR was prepared and stored at 4°C, the standard curves were almost same in daily measurement. When we evaluated the same batch of immunocomplex SR every day for 5 d, we found that the CV of percent B/Bo (mP response for bound progesterone over mP response for zero concentration of progesterone) was 1.8-2.8% in the range of the standard curve. This is one of the advantages of better points for one-step FPIA compared with FPIA in which the respective solutions of tracer and antiserum are unstable, and we prepared each dilution of both reagent solutions fresh daily. It was reported that a single reagent for drugs of abuse may be stable for more than 1 month.
14)
The detection limit was 2.7 ng/ml by calculating the 95% confidence limit distinguished from zero concentration in 5 replicate assays. This is comparable with that of FPIA in a previous report. 12) The urinary progesterone level reported was 11.1 mg/ml in the luteal phase and 38.3 mg/ml in early pregnancy. 17) Therefore this method could be useful to determine urinary progesterone levels in early pregnancy. Assay precisions were studied at two concentrations of controls for every assay. Within-run CVs (nϭ5) ranged between 2.6 and 8.5% for controls containing progesterone 50 ng/ml and 206 ng/ml. CVs for run-to-run precision (nϭ3) were 13%. Studies for dilution recovery were performed using 4-fold double dilutions of known concentrations of control samples, and the mean recovery was 102 and 95% (Table 3 ). The specificity results (Table 4) showed a high cross-reactivity with 11a-hydroxyprogesterone (537%) as well as progesterone (100%). This result is probably attributable to the PAb #1 antibody used in this assay for which the immunogen (P-11HS-BSA) was derivatized at the C11-position of the progesterone C-ring. A similar trend was reported. Previously 12) However, 20a-hydroxyprogesterone (88%) and 17a-hydroxyprogesterone (5%) showed different cross-reactivity, indicating that the binding pocket of antibody plays an important role at the functional group of the D-ring of steroids. The cross-reactivity was very low for androsterone (5%), testosterone (6%), cortisone (3%), and cortisol (1%), which have the main difference in the functional groups of the steroid Dring.
In conclusion, we demonstrated a new one-step FPIA method for the measurement of progesterone levels using an immunocomplex SR that is a mixture of tracer and antiserum. The reagent is more stable than the respective solutions of tracer and antiserum for assay. This method is very simple and rapid because it requires only simple mixing of sample with the immunocomplex SR, followed by measurement of fluorescence polarization. The detection limit was 2.7 ng/ml using 50 ml of sample. The performance characteristics are acceptable for standard curve reproducibility, precision, dilution recovery, and cross-reactivity. It therefore is applicable to monitoring progesterone levels in biological samples. Vol. 25, No. 10 a) IC 50 means a concentration of 50% displacement by a free analyte in a competitive immunoassay. b) % cross-reactivity defined as % ratio of concentration for 50% displacement by progesterone concentration/50% displacement by analogue concentration. 
